Irbesartan

• Recruiting NCT NCT02735707

  Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

  Not yet reported UMC Utrecht 20000 participants Est. completion 2028-02 408 sites
  Other conditions: Community-acquired Pneumonia, Influenza, COVID-19
  View official trial listing →
• Recruiting NCT NCT02817360

  NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

  Not yet reported Martin Huelsmann 2400 participants Est. completion 2026-12 21 sites
  Type 2 diabetes Other conditions: Heart Diseases
  View official trial listing →
• Recruiting NCT NCT03476603

  Bariatric Surgery and Pharmacokinetics of Irbesartan

  Norwegian University of Science and Technology 12 participants Est. completion 2026-10 1 site
  Other conditions: Obesity, Morbid
  View official trial listing →
• Recruiting NCT NCT05498675

  Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

  Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 site
  Other conditions: Sacubitril/Valsartan, Hypertension, Obesity
  View official trial listing →
• Completed NCT NCT00005010

  Prevention of Kidney Transplant Rejection

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2004-03 1 site
  Other conditions: End-Stage Renal Disease, Chronic Allograft Nephropathy
  View official trial listing →
• Completed NCT NCT00095238

  Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)

  Not yet reported Bristol-Myers Squibb 4128 participants Est. completion 2008-07 229 sites
  Heart failure
  View official trial listing →
• Completed NCT NCT00095290

  Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

  Not yet reported Bristol-Myers Squibb 400 participants Est. completion 2005-11 92 sites Stand-alone
  Other conditions: Albuminuria
  View official trial listing →
• Completed NCT NCT00095394

  Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension

  Not yet reported Bristol-Myers Squibb 645 participants Est. completion 2005-05 269 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00095550

  Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension

  Not yet reported Bristol-Myers Squibb 496 participants Est. completion 2005-06 128 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00106561

  Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney

  Not yet reported, Not yet reported Melbourne Health 60 participants Est. completion 2004-09 1 site
  Chronic kidney disease Other conditions: Kidney Disease, Glomerulonephritis, Proteinuria
  View official trial listing →
• Completed NCT NCT00110422

  Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome

  Not yet reported Bristol-Myers Squibb 400 participants Est. completion 2007-02 25 sites Stand-alone
  Metabolic syndrome Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00125645

  Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)

  Not yet reported University of Southern Denmark 200 participants Est. completion 2011-09-01 1 site Stand-alone
  Cardiovascular disease
  View official trial listing →
• Withdrawn NCT NCT00152698

  Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia

  Not yet reported University of Erlangen-Nürnberg Medical School Est. completion 2009-12 1 site
  Other conditions: Hypercholesterolemia
  View official trial listing →
• Completed NCT NCT00154024

  Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin.

  Not yet reported Technische Universität Dresden Est. completion 2006-10 1 site
  Other conditions: Healthy Subjects
  View official trial listing →
• Completed NCT NCT00171080

  VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis

  Not yet reported Novartis 86 participants Est. completion 2006-03 2 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00180024

  Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.

  Not yet reported Technische Universität Dresden Est. completion 2005-09 1 site
  Other conditions: Healthy Subjects
  View official trial listing →
• Completed NCT NCT00185055

  The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects

  Not yet reported Daiichi Sankyo 20 participants Est. completion 2005-02
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT00219115

  A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg

  Not yet reported Novartis 493 participants Est. completion 2006-03 2 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00224549

  PHARES Study: Management of Resistant Hypertension

  Not yet reported Assistance Publique - Hôpitaux de Paris 180 participants Est. completion 2009-08 1 site
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT00225667

  Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers

  Not yet reported Connolly, Stuart, M.D. 200 participants Est. completion 2007-07 1 site
  Other conditions: Atrial Fibrillation, Hypertension
  View official trial listing →
• Terminated NCT NCT00243178

  Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)

  Not yet reported Sanofi 6706 participants Est. completion 2005-09 32 sites
  Other conditions: Atrial Fibrillation, Vascular Risk
  View official trial listing →
• Completed NCT NCT00249795

  Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)

  Not yet reported Sanofi 9016 participants Est. completion 2009-08 30 sites Stand-alone
  Cardiovascular disease Other conditions: Atrial Fibrillation
  View official trial listing →
• Completed NCT NCT00249873

  Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)

  Not yet reported Sanofi 7554 participants Est. completion 2009-03 30 sites
  Other conditions: Atrial Fibrillation, Vascular Risk
  View official trial listing →
• Completed NCT NCT00263003

  Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension

  Not yet reported Sanofi 40 participants 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00264212

  AMISH : Aprovel for Management of Isolated Systolic Hypertension

  Not yet reported Sanofi 436 participants 8 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00265642

  Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C

  Not yet reported ANRS, Emerging Infectious Diseases 166 participants Est. completion 2013-11 1 site Stand-alone
  Other conditions: Hepatitis C, Chronic
  View official trial listing →
• Completed NCT NCT00265967

  Irbesartan in Hypertension

  Not yet reported Sanofi 88 participants 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00283036

  APROVE : Irbesartan in Hypertension

  Not yet reported Sanofi 200 participants 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00296218

  ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation

  Not yet reported Sanofi 440 participants 11 sites
  Other conditions: Myocardial Ischemia, Hypertension
  View official trial listing →
• Completed NCT NCT00317915

  Irbesartan in Type 2 Diabetes

  Not yet reported Steno Diabetes Center Copenhagen
  Type 2 diabetes Other conditions: Microalbuminuria, Hypertension
  View official trial listing →
• Completed NCT NCT00320879

  Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria

  Not yet reported Steno Diabetes Center Copenhagen 52 participants Est. completion 2004-11 1 site
  Type 2 diabetes Other conditions: Microalbuminuria
  View official trial listing →
• Completed NCT NCT00334581

  Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria

  Not yet reported Sanofi 192 participants Est. completion 2008-06 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00335673

  I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients

  Not yet reported Sanofi 1630 participants Est. completion 2006-11 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00343551

  Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.

  Not yet reported Novartis 654 participants 2 sites
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT00347087

  Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure

  Not yet reported Charite University, Berlin, Germany 36 participants Est. completion 2007-06 1 site
  Heart failure
  View official trial listing →
• Completed NCT NCT00350038

  Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions

  Not yet reported Sanofi 60 participants Est. completion 2007-08 1 site
  Other conditions: Hypertension, Dyslipidemia
  View official trial listing →
• Completed NCT NCT00352560

  Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF)

  Not yet reported Bristol-Myers Squibb 44 participants Est. completion 2007-06 3 sites
  Other conditions: Atrial Fibrillation
  View official trial listing →
• Completed NCT NCT00362037

  I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy

  Not yet reported Sanofi 281 participants Est. completion 2008-06 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00362258

  I PREVENT - Irbesartan In Hypertensive Diabetic Patients

  Not yet reported Sanofi 797 participants Est. completion 2008-09 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00389168

  Irbesartan and Atenolol in Hypertensive Heart Disease

  Not yet reported, Not yet reported Karolinska Institutet 115 participants Est. completion 1997-04 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00443612

  Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing

  Not yet reported Sanofi 60 participants 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00464880

  Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy

  Not yet reported, Not yet reported Novartis 24 participants Est. completion 2007-11 1 site
  Other conditions: Diabetes Type 2
  View official trial listing →
• Completed NCT NCT00500604

  Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension

  Not yet reported Sanofi 1617 participants Est. completion 2010-01 14 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT00517322

  Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan

  Not yet reported Università degli Studi dell'Insubria 80 participants Est. completion 2010-08 1 site Stand-alone
  Other conditions: Left Atrial Volume, Hypertensive Heart Disease, Antihypertensive Drugs, Diastolic Function, Renin Angiotensin System
  View official trial listing →
• Completed NCT NCT00529750

  Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension

  Not yet reported Sanofi 108 participants Est. completion 2005-01 Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00535925

  Nephropathy In Type 2 Diabetes and Cardio-renal Events

  Not yet reported University of Campania Luigi Vanvitelli 850 participants Est. completion 2019-05 1 site Stand-alone
  Chronic kidney disease
  View official trial listing →
• Completed NCT NCT00549133

  Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol

  Not yet reported Sanofi 44 participants Est. completion 2005-04 1 site
  Type 2 diabetes Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00561964

  Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria

  Not yet reported Sanofi 241 participants Est. completion 2005-07 Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00562809

  The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension

  Not yet reported Sanofi 1005 participants Est. completion 2004-08 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00564187

  Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice

  Not yet reported Sanofi 115 participants Est. completion 2004-12 1 site
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT00613496

  Irbesartan and Adhesion Molecules in AF

  Not yet reported University of Magdeburg 60 participants Est. completion 2010-05 1 site
  Other conditions: Persistent Atrial Fibrillation
  View official trial listing →
• Completed NCT NCT00635232

  A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension

  Not yet reported Ligand Pharmaceuticals 261 participants Est. completion 2008-12 40 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00657059

  Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)

  Not yet reported Sun Yat-sen University 151 participants Est. completion 2019-05 1 site
  Other conditions: IgA Nephropathy
  View official trial listing →
• Completed NCT NCT00660309

  A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus

  Not yet reported Novartis 45 participants Est. completion 2009-12 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00670566

  Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients

  Not yet reported Sanofi 503 participants 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00684489

  Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

  Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00708344

  ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination

  Not yet reported Sanofi 832 participants Est. completion 2009-07 16 sites
  Other conditions: Hypertension
  View official trial listing →
• Withdrawn NCT NCT00713011

  Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients

  Not yet reported Bayer Est. completion 2009-03 Stand-alone
  Other conditions: Diabetic Nephropathies, Hypertension
  View official trial listing →
• Completed NCT NCT00741585

  Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment

  Not yet reported University of Vigo 21983 participants Est. completion 2018-06-30 20 sites
  Cardiovascular diseaseChronic kidney disease Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT00741702

  Diabetes Risk Evaluation and Microalbuminuria in Saskatchewan First Nations Peoples

  Not yet reported Sunnybrook Health Sciences Centre 95 participants Est. completion 2003-03 Stand-alone
  Other conditions: Hypertension, Diabetes Mellitus
  View official trial listing →
• Status unknown NCT NCT00742066

  Role of AT1-receptor Blockers in Insulin-induced Vasodilation.

  Not yet reported Maastricht University Medical Center 32 participants Est. completion 2009-07 1 site Stand-alone
  Other conditions: Hypertension, Insulin Resistance, Microcirculation
  View official trial listing →
• Completed NCT NCT00791830

  Saving Residual Renal Function Among Haemodialysis Patients Receiving Irbesartan

  Not yet reported University of Aarhus 82 participants Est. completion 2013-01 6 sites
  Other conditions: Kidney Failure, Chronic
  View official trial listing →
• Terminated NCT NCT00794963

  Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia

  Not yet reported Northwell Health 8 participants Est. completion 2010-05 1 site Stand-alone
  Metabolic syndrome
  View official trial listing →
• Completed NCT NCT00847834

  Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population

  Not yet reported Sanofi 968 participants 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00933231

  Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

  Not yet reported Astellas Pharma Inc 281 participants Est. completion 2018-04-03 13 sites Stand-alone
  Other conditions: Kidney Transplantation
  View official trial listing →
• Completed NCT NCT00950066

  Irbesartan and Amlodipine Combination in Controlling Blood Pressure

  Not yet reported Sanofi 270 participants Est. completion 2010-01 4 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00956644

  Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy

  Not yet reported Sanofi 406 participants Est. completion 2010-08 40 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00957554

  Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy

  Not yet reported Sanofi 435 participants Est. completion 2010-09 38 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Withdrawn NCT NCT00987662

  Irbesartan Versus Amlodipine: The OBI Study

  Not yet reported Aristotle University Of Thessaloniki Est. completion 2014-01 1 site
  Other conditions: Obesity, Hypertension
  View official trial listing →
• Status unknown NCT NCT01082835

  Jiangzhuo Qinggan Prescription and Irbesartan in the Treatment of Essential Hypertension(Hepatogastric Damp-heat)Clinical Study

  Guang'anmen Hospital of China Academy of Chinese Medical Sciences 240 participants Est. completion 2010-08 5 sites
  Metabolic syndrome Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01109212

  The Effects of Bindarit in Diabetic Nephropathy

  Not yet reported Aziende Chimiche Riunite Angelini Francesco S.p.A 100 participants Est. completion 2008-12 6 sites Stand-alone
  Chronic kidney disease
  View official trial listing →
• Completed NCT NCT01195818

  Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients

  Not yet reported Assistance Publique - Hôpitaux de Paris 53 participants Est. completion 2014-09 1 site Stand-alone
  Other conditions: Sickle Cell Disease
  View official trial listing →
• Status unknown NCT NCT01238705

  Combined Antihypertensive Therapy and Sexual Dysfunction

  Not yet reported LanZhou University 280 participants Est. completion 2010-11 1 site
  Other conditions: Hypertension, Sexual Dysfunction
  View official trial listing →
• Status unknown NCT NCT01360710

  The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension

  Not yet reported Baker Heart and Diabetes Institute 100 participants 1 site
  Other conditions: Abdominal Obesity, Hypertension
  View official trial listing →
• Status unknown NCT NCT01377285

  Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)

  Not yet reported National Taiwan University Hospital 350 participants Est. completion 2018-12 1 site Stand-alone
  Other conditions: Chronic Renal Failure
  View official trial listing →
• Completed NCT NCT01442987

  Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia

  Not yet reported Hanmi Pharmaceutical Company Limited 230 participants Est. completion 2013-05 1 site Stand-alone
  Other conditions: Hypertension, Hyperlipidemia
  View official trial listing →
• Completed NCT NCT01447797

  A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin

  Not yet reported Hanmi Pharmaceutical Company Limited 52 participants Est. completion 2011-12 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Status unknown NCT NCT01500590

  Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria

  Not yet reported Hospital Authority, Hong Kong 1400 participants Est. completion 2019-08 1 site Stand-alone
  Other conditions: Diabetes, Hypertensive Disease
  View official trial listing →
• Suspended NCT NCT01519297

  Preeclampsia: A Marker for Future Cardiovascular Risk in Women

  Not yet reported Brigham and Women's Hospital 150 participants Est. completion 2019-07 1 site
  Other conditions: Preeclampsia, Pregnancy Induced Hypertension
  View official trial listing →
• Completed NCT NCT01588795

  Renal Denervation in Diabetic Nephropathy

  Not yet reported Assistance Publique - Hôpitaux de Paris 25 participants Est. completion 2016-01 1 site
  Chronic kidney disease Other conditions: Persistent Proteinuria With Type II Diabetes
  View official trial listing →
• Completed NCT NCT01613118

  Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis

  Not yet reported Travere Therapeutics, Inc. 109 participants Est. completion 2024-03-25 33 sites Stand-alone
  Other conditions: Focal Segmental Glomerulosclerosis
  View official trial listing →
• Completed NCT NCT01625494

  Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy

  Not yet reported Sanofi 158 participants Est. completion 2013-01 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01712100

  Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions

  Not yet reported Roxane Laboratories 34 participants Est. completion 2007-08 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01712113

  Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted Conditions

  Not yet reported Roxane Laboratories 33 participants Est. completion 2007-08 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01712126

  Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions

  Not yet reported Roxane Laboratories 40 participants Est. completion 2007-09 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01712139

  Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions

  Not yet reported Roxane Laboratories 37 participants Est. completion 2007-09 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT01715584

  Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics

  Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01825850

  Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects

  Not yet reported LG Life Sciences 30 participants Est. completion 2014-03 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT01858610

  Drug Interaction Between Irbesartan and Hydrochlorothiazide

  Not yet reported Damanhour University 18 participants Est. completion 2013-04 1 site
  Other conditions: Healthy
  View official trial listing →
• Status unknown NCT NCT01949233

  The Oxford Marfan Trial

  Not yet reported University of Oxford 56 participants Est. completion 2017-12 2 sites Stand-alone
  Other conditions: Marfan Syndrome
  View official trial listing →
• Completed NCT NCT01968759

  Sevelamer in Proteinuric CKD

  Not yet reported Mario Negri Institute for Pharmacological Research 53 participants Est. completion 2015-10 2 sites Stand-alone
  Chronic kidney disease
  View official trial listing →
• Status unknown NCT NCT01992796

  Angiotensin II Antagonist in Severe Sepsis

  Not yet reported University of Salerno 300 participants Est. completion 2017-01 1 site Stand-alone
  Other conditions: Severe Sepsis
  View official trial listing →
• Completed NCT NCT02148991

  Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction

  Elpen Pharmaceutical Co. Inc. 100 participants Est. completion 2017-01 2 sites
  Other conditions: Hypertension, Cardiac Arrhythmias, Diabetes Mellitus, Renal Insufficiency, Sleep Apnea
  View official trial listing →
• Status unknown NCT NCT02380625

  Multiple Treatments for Ebola Virus Disease (EVD)

  Not yet reported, Not yet reported Clinical Research Management, Inc. 150 participants Est. completion 2016-03 Stand-alone
  Other conditions: Ebola Virus Disease
  View official trial listing →
• Status unknown NCT NCT02386293

  Effectiveness of Avapro in Obese Normotensive/Hypertensive African Americans

  Not yet reported Augusta University 30 participants Est. completion 2019-11-30 1 site
  Other conditions: Hypertension, Obesity, Stress, Psychological, Blood Pressure
  View official trial listing →
• Status unknown NCT NCT02502110

  Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation

  Not yet reported The Third Xiangya Hospital of Central South University 346 participants Est. completion 2019-06
  Other conditions: Paroxysmal Atrial Fibrillation
  View official trial listing →
• Terminated NCT NCT02539810

  Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)

  Not yet reported Assistance Publique - Hôpitaux de Paris 4 participants Est. completion 2017-07 15 sites Stand-alone
  Other conditions: Hypertension, Hypertension Resistant to Conventional Therapy, Angiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 Percent
  View official trial listing →
• Completed NCT NCT02597361

  Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)

  Not yet reported Assistance Publique - Hôpitaux de Paris 61 participants Est. completion 2020-02-19 15 sites
  Other conditions: Ehlers-Danlos Syndrome, Vascular Type
  View official trial listing →
• Terminated NCT NCT02644486

  A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy

  Not yet reported Zhi-Hong Liu, M.D. 4 participants Est. completion 2018-02 1 site Stand-alone
  Other conditions: Obesity and Glomerulopathy
  View official trial listing →
• Status unknown NCT NCT02721342

  Remission Clinic in Proteinuric Chronic Nephropathies

  Mario Negri Institute for Pharmacological Research 1500 participants Est. completion 2022-11 13 sites
  Chronic kidney disease
  View official trial listing →
• Completed NCT NCT02842359

  Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension

  Not yet reported Sanofi 11 participants Est. completion 2018-04-19 1 site Stand-alone
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT03006796

  Observational Study of Azilsartan/Chlorthalidone and Irbesartan/Hydrochlorothiazide in Hypertension and Obesity.

  Russian Heart Failure Society 94 participants Est. completion 2020-03-31 1 site
  Other conditions: Arterial Hypertension
  View official trial listing →
• Status unknown NCT NCT03016832

  Clinical Trial of HuangKui Capsule to Treat Diabetic Kidney Disease

  Not yet reported Jiangsu Famous Medical Technology Co., Ltd. 414 participants Est. completion 2018-12 1 site Stand-alone
  Chronic kidney disease
  View official trial listing →
• Completed NCT NCT03147677

  Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan

  Not yet reported The Third Xiangya Hospital of Central South University 60 participants Est. completion 2018-12-30 3 sites Stand-alone
  Chronic kidney disease
  View official trial listing →
• Completed NCT NCT03476616

  Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients

  Not yet reported Hippocration General Hospital 198 participants Est. completion 2025-06-30 1 site
  Other conditions: Hypertension, Obesity
  View official trial listing →
• Completed NCT NCT03493685

  Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)

  Not yet reported Travere Therapeutics, Inc. 371 participants Est. completion 2026-03-19 226 sites
  Other conditions: Focal Segmental Glomerulosclerosis
  View official trial listing →
• Completed NCT NCT03627715

  Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan

  Not yet reported Dimerix Bioscience Pty Ltd 45 participants Est. completion 2020-08-18 13 sites
  Chronic kidney disease
  View official trial listing →
• Completed NCT NCT03649152

  Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan

  Not yet reported Dimerix Bioscience Pty Ltd 8 participants Est. completion 2020-07-13 11 sites
  Other conditions: Focal Segmental Glomerulosclerosis
  View official trial listing →
• Active, not recruiting NCT NCT03762850

  A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy

  Not yet reported Travere Therapeutics, Inc. 406 participants Est. completion 2026-07 162 sites
  Other conditions: Immunoglobulin A Nephropathy
  View official trial listing →
• Completed NCT NCT03934307

  A Study to Evaluate ALN-AGT01 in Patients With Hypertension

  Not yet reported Alnylam Pharmaceuticals 124 participants Est. completion 2023-01-04 3 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT04061824

  Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

  Not yet reported Yonsei University 150 participants Est. completion 2018-12-20 1 site
  Other conditions: Hypertension, Dyslipidemias
  View official trial listing →
• Suspended NCT NCT04330300

  Coronavirus (COVID-19) ACEi/ARB Investigation

  Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 site
  Other conditions: Hypertension, COVID-19
  View official trial listing →
• Completed NCT NCT04394117

  Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

  Not yet reported The George Institute 787 participants Est. completion 2022-01-17 22 sites
  Other conditions: Coronavirus Disease 2019, COVID-19
  View official trial listing →
• Completed NCT NCT04467931

  ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

  University of Utah 22213 participants Est. completion 2020-12-31 1 site
  Other conditions: Hypertension, COVID
  View official trial listing →
• Completed NCT NCT04488978

  Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension

  Not yet reported Handok Inc. 440 participants Est. completion 2021-11-09 1 site Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Terminated NCT NCT04606563

  Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?

  Not yet reported University of British Columbia 341 participants Est. completion 2022-04-22 13 sites Stand-alone
  Other conditions: Covid19, SARS-CoV Infection
  View official trial listing →
• Status unknown NCT NCT04743063

  Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

  Brigham and Women's Hospital 40000 participants Est. completion 2022-12-31 1 site
  Heart failure Other conditions: Frailty
  View official trial listing →
• Completed NCT NCT04981613

  Study on the Efficacy and Safety of a Novel Tripterygium Wilfordii Preparation in Reducing Proteinuria in Patients With Diabetic Nephropathy

  Not yet reported First Affiliated Hospital Xi'an Jiaotong University 80 participants Est. completion 2024-08-28 1 site Stand-alone
  Chronic kidney disease
  View official trial listing →
• Terminated NCT NCT05056727

  A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

  Not yet reported AstraZeneca 1112 participants Est. completion 2024-02-07 276 sites Stand-alone
  Other conditions: Renal Insufficiency, Chronic, Hyperkalemia
  View official trial listing →
• Completed NCT NCT05243199

  Sacubitril/Valsartan for CKD5 Stage Dialysis Patients

  Not yet reported Ruijin Hospital 330 participants Est. completion 2023-03-08 1 site
  Chronic kidney diseaseHeart failure
  View official trial listing →
• Active, not recruiting NCT NCT05272878

  Impact of a Treatment With Angiotensin Receptor Blocker on Outcome After Acute Kidney Injury in Patients Discharged From the ICU.

  Not yet reported Assistance Publique - Hôpitaux de Paris 508 participants Est. completion 2026-06-27 1 site
  Other conditions: Acute Kidney Injury
  View official trial listing →
• Status unknown NCT NCT05297929

  A Bioequivalence Trial of Irbesartan Tablets（0.15g） in Healthy Chinese Subjects

  Not yet reported The Affiliated Hospital of Qingdao University 54 participants Est. completion 2022-12-31 1 site Stand-alone
  Other conditions: Irbesartan Tablets (0.15g/Tablet), Under Fasted Condition, Under Fed Condition, Bioequivalence
  View official trial listing →
• Completed NCT NCT05377203

  Low-dose Quadruple Combination Therapy in Patients With Hypertension

  Not yet reported The Third Xiangya Hospital of Central South University 90 participants Est. completion 2023-07-04 1 site Stand-alone
  Other conditions: Hypertension, Arterial Hypertension
  View official trial listing →
• Completed NCT NCT05475665

  Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients

  Not yet reported Handok Inc. 157 participants Est. completion 2023-06-13 1 site Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT05476354

  Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients

  Not yet reported Handok Inc. 271 participants Est. completion 2023-06-13 1 site Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Active, not recruiting NCT NCT05630612

  ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)

  Not yet reported University of Edinburgh 32 participants Est. completion 2027-09-01 1 site Stand-alone
  Cardiovascular disease Other conditions: ANCA Associated Vasculitis, Kidney Diseases
  View official trial listing →
• Completed NCT NCT05663073

  Pharmacokinetics of Irbesartan/Amlodipine FDC and Co-administration of Irbesartan and Amlodipine in Healthy Volunteers

  Not yet reported Handok Inc. 46 participants Est. completion 2023-04-21 1 site Stand-alone
  Other conditions: Healthy Volunteers
  View official trial listing →
• Status unknown NCT NCT05670028

  Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization

  Not yet reported Beijing Tiantan Hospital 100 participants Est. completion 2026-06-04 Stand-alone
  Cardiovascular disease Other conditions: Revascularization, Blood Pressure, Cerebrovascular Insufficiency, Cerebral Autoregulation, Individuation
  View official trial listing →
• Completed NCT NCT05688085

  Pharmacokinetics of Irbesartan High/Amlodipine FDC and Co-administration of Irbesartan High and Amlodipine in Healthy Volunteers

  Not yet reported Handok Inc. 44 participants Est. completion 2023-04-21 1 site Stand-alone
  Other conditions: Healthy Volunteers
  View official trial listing →
• Completed NCT NCT05688098

  Pharmacokinetics of Irbesartan/Amlodipine High FDC and Co-administration of Irbesartan and Amlodipine High in Healthy Volunteers

  Not yet reported Handok Inc. 44 participants Est. completion 2023-04-21 1 site
  Other conditions: Healthy Volunteers
  View official trial listing →
• Completed NCT NCT05786339

  Bioequivalence Study of Two Irbesartan in Healthy Chinese Subjects

  Not yet reported The Affiliated Hospital of Qingdao University 68 participants Est. completion 2019-05-15 1 site Stand-alone
  Other conditions: Therapeutic Equivalency
  View official trial listing →
• Status unknown NCT NCT06208072

  The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.

  Not yet reported Hippocration General Hospital 50 participants Est. completion 2025-02-01 1 site
  Other conditions: Primary Hypertension, Obesity
  View official trial listing →
• Status unknown NCT NCT06515678

  Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

  Groupe Hospitalier Pitie-Salpetriere 9464 participants Est. completion 2024-08-31 2 sites
  Other conditions: Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab, Hypertension
  View official trial listing →
• Not yet recruiting NCT NCT06635772

  A Study of the Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy

  Not yet reported Hansoh BioMedical R&D Company 90 participants Est. completion 2026-04-30 1 site
  Other conditions: Immunoglobulin a Nephropathy
  View official trial listing →
• Not yet recruiting NCT NCT06660940

  Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic Retinopathy

  Not yet reported Chinese PLA General Hospital 460 participants Est. completion 2027-10 Stand-alone
  Chronic kidney disease Other conditions: Diabetic Retinopathy
  View official trial listing →
• Not yet recruiting NCT NCT06790927

  Standardized Antihypertensive Treatment Protocol

  Not yet reported Shanghai Jiao Tong University School of Medicine 400 participants Est. completion 2026-12-31 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Not yet recruiting NCT NCT07262710

  Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

  First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19
  Cardiovascular disease
  View official trial listing →
• Not yet recruiting NCT NCT07360002

  The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA Nephropathy

  Not yet reported Keda Lu 102 participants Est. completion 2026-12 Stand-alone
  Other conditions: IgA Nephropathy (IgAN)
  View official trial listing →
• Enrolling by invitation NCT NCT07547878

  Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

  Not yet reported Baylor Research Institute 64 participants Est. completion 2029-03-31 1 site
  Chronic kidney diseaseType 2 diabetes
  View official trial listing →
• Not yet recruiting NCT NCT07555054

  A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease

  Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 182 participants Est. completion 2028-12-31 1 site
  Chronic kidney disease
  View official trial listing →

Not yet reported.

Not yet reported.

• ClinicalTrials.gov — NCT07547878

Also known as: Irbesartan, Avapro

No related coverage yet.